SBI Japan-Israel Innovation Fund

Type

Venture Capital

Status

Active

Location

Tel Aviv, Israel

Total investments

9

Average round size

24M

Portfolio companies

7

Rounds per year

2.25

Follow on index

0.22

Exits

3

Stages of investment
Early Stage Venture
Areas of investment
BiotechnologyHealth CareGeneticsMedicalPharmaceuticalTherapeuticsClinical Trials

Summary

The venture was found in Asia in Israel. The main department of described VC is located in the Herzliya.

The fund has no exact preference in a number of founders of portfolio startups. In case when startup counts 3 or 5+ of the founder, the chance for it to get the investment is meager. Among the most popular fund investment industries, there are Biotechnology, Clinical Trials. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline BIOMx, Orasis Pharmaceuticals, ChemomAb For fund there is a match between the country of its foundation and the country of its the most frequent investments - Israel.

Besides them, we counted 3 critical employees of this fund in our database.

The important activity for fund was in 2019. The fund is constantly included in 2-6 deals per year. The top amount of exits for fund were in 2018. Comparing to the other companies, this SBI Japan-Israel Innovation Fund performs on 15 percentage points less the average number of lead investments. Deals in the range of 10 - 50 millions dollars are the general things for fund.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the SBI Japan-Israel Innovation Fund, startups are often financed by OrbiMed, Takeda Ventures, Seventure Partners. The meaningful sponsors for the fund in investment in the same round are OrbiMed, Takeda Ventures, Seventure Partners. In the next rounds fund is usually obtained by Takeda Ventures, Seventure Partners, RM Global Partners.

Show more

Investor highlights

Industry focus
Biotech/Life Sciences
Stage focus
GeneralistPre-SeedSeedSeries ASeries B Show 1 more

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
9
Lead investments
0
Exits
3
Rounds per year
2.25
Follow on index
0.22
Investments by industry
  • Biotechnology (7)
  • Health Care (7)
  • Pharmaceutical (6)
  • Therapeutics (3)
  • Medical (2)
  • Show 2 more
Investments by region
  • Israel (8)
  • United States (1)
Peak activity year
2017

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
8
Group Appearance index
1.00

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Orasis Pharmaceuticals 05 Jun 2018 Health Care, Medical, Pharmaceutical, Clinical Trials Early Stage Venture 13M Tel Aviv District, Israel, Israel

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.